Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $26.68 USD
Change Today +0.10 / 0.38%
Volume 172.5K
AMED On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 4:30 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (AMED) Snapshot

Open
$26.63
Previous Close
$26.58
Day High
$27.05
Day Low
$26.40
52 Week High
02/27/15 - $31.27
52 Week Low
05/8/14 - $12.86
Market Cap
898.4M
Average Volume 10 Days
227.0K
EPS TTM
$0.63
Shares Outstanding
33.7M
EX-Date
--
P/E TM
42.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (AMED)

amedisys inc (AMED) Related Businessweek News

View More BusinessWeek News

amedisys inc (AMED) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

13,200 Employees
Last Reported Date: 03/4/15
Founded in 1982

amedisys inc (AMED) Top Compensated Officers

Chief Medical Officer
Total Annual Compensation: $308.5K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $277.3K
Chief Compliance Officer and Corporate Counse...
Total Annual Compensation: $270.6K
Compensation as of Fiscal Year 2013.

amedisys inc (AMED) Key Developments

Amedisys Inc. Reports Unaudited Consolidated Financial Results for the Fourth Quarter and Year Ended December 31, 2014

Amedisys Inc. reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported net service revenue of $300,528,000 compared to $303,497,000 a year ago. Operating income was $14,811,000 compared to operating loss of $10,362,000 a year ago. Income before income taxes was $14,519,000 compared to loss before income tax of $13,556,000 a year ago. Loss from continuing operations was $9,331,000 compared to income from continuing operations of $8,518,000 a year ago. Net income was $9,331,000 compared to net loss of $9,977,000 a year ago. Net income attributable to the company was $9,135,000 or $0.28 per basic and diluted share compared to net loss attributable to the company $9,628,000 or $0.30 per basic and diluted share a year ago. Amounts attributable to the company common stockholders income from continuing operations were $9,135,000 compared to amounts attributable to the company common stockholders loss from continuing operations $8,169,000 a year ago. Net cash provided by operating activities was $4,595,000 compared to $8,401,000 a year ago. EBITDA was $23,087,000 compared to LBITDA of $2,722,000 a year ago. Adjusted EBITDA was $22,873,000 compared to $6,786,000 a year ago. Adjusted net loss from continuing operations attributable to the company of $8,997,000 or $0.27 per diluted share compared to adjusted net loss from continuing operations of $2,239,000 or $0.07 per diluted share a year ago. For the year, the company reported net service revenue of $1,204,554,000 compared to $1,249,344,000 a year ago. Operating income was $24,047,000 compared to operating loss of $154,971,000 a year ago. Income before income taxes was $20,976,000 compared to loss before income taxes of $153,475,000 a year ago. Income from continuing operations was $13,305,000 compared to loss from continuing operations of $94,702,000 a year ago. Net income was $13,089,000 compared to net loss of $97,775,000 a year ago. Net income attributable to the company was $12,776,000 or $0.39 per basic and diluted share compared to net loss attributable to the company of $96,178,000 or $3.08 per basic and diluted share a year ago. Amounts attributable to the company common stockholders income from continuing operations were $12,992,000 compared to amounts attributable to the company common stockholders loss from continuing operations $93,105,000 a year ago. Net cash used in operating activities was $65,534,000 compared to net cash provided by operating activities of $102,263,000 a year ago. EBITDA was $57,093,000 compared to LBITDA of $110,649,000 a year ago. Adjusted EBITDA was $74,278,000 compared to $54,375,000 a year ago. Adjusted net income from continuing operations attributable to the company on guidance basis was $23,872,000 or $0.73 per diluted share compared to $5,221,000 or $0.16 per diluted share a year ago. Total capital expenditures was $12 million.

Amedisys Seeks Acquisitions

Paul Kusserow, President & Chief Executive Officer of Amedisys Inc. (NasdaqGS:AMED) while commenting on M&A activity said that the key thing is that we are back looking at deals and we are looking at really interesting deals. What we are going to try to do is be very conservative, I think, initially. So what we want to do is we want to make sure that there's tuck-ins that are accretive, that are in the market, that are additive, that come under good management teams, and are in home health or in hospice, so that we can get these under our belt, understand how these things are working. I think that is where we are going to focus. As we get better at this, we will start to look more expansively and look at some of these other deals that are out there that can take us into new geographies where we feel we need to be playing.

Amedisys Inc. to Report Q4, 2014 Results on Mar 04, 2015

Amedisys Inc. announced that they will report Q4, 2014 results at 10:00 AM, US Eastern Standard Time on Mar 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMED:US $26.68 USD +0.10

AMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Capital Senior Living Corp $25.44 USD +0.04
Chemed Corp $120.67 USD -0.17
Five Star Quality Care Inc $4.35 USD +0.13
National HealthCare Corp $63.99 USD +0.03
Ensign Group Inc/The $47.41 USD +2.05
View Industry Companies
 

Industry Analysis

AMED

Industry Average

Valuation AMED Industry Range
Price/Earnings 67.2x
Price/Sales 0.7x
Price/Book 2.2x
Price/Cash Flow 21.8x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.